Influence of the tumor microenvironment on NK cell function in solid tumors
Natural killer (NK) cells are a population of innate lymphoid cells playing a pivotal role in
host immune responses against infection and tumor growth. These cells have a powerful …
host immune responses against infection and tumor growth. These cells have a powerful …
Therapeutic targeting of regulatory T cells in cancer
F Shan, A Somasundaram, TC Bruno, CJ Workman… - Trends in cancer, 2022 - cell.com
The success of immunotherapy in oncology underscores the vital role of the immune system
in cancer development. Regulatory T cells (Tregs) maintain a fine balance between …
in cancer development. Regulatory T cells (Tregs) maintain a fine balance between …
Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling
F Xie, X Zhou, P Su, H Li, Y Tu, J Du, C Pan… - Nature …, 2022 - nature.com
Cancer immunotherapies have shown clinical success in various types of tumors but the
patient response rate is low, particularly in breast cancer. Here we report that malignant …
patient response rate is low, particularly in breast cancer. Here we report that malignant …
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
UM Cytlak, DP Dyer, J Honeychurch… - Nature Reviews …, 2022 - nature.com
Radiotherapy (RT) is a highly effective anticancer treatment that is delivered to more than
half of all patients with cancer. In addition to the well-documented direct cytotoxic effects, RT …
half of all patients with cancer. In addition to the well-documented direct cytotoxic effects, RT …
Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies
I Lurje, NT Gaisa, R Weiskirchen, F Tacke - Molecular Aspects of Medicine, 2023 - Elsevier
Fibrosis, or tissue scarring, develops as a pathological deviation from the physiological
wound healing response and can occur in various organs such as the heart, lung, liver …
wound healing response and can occur in various organs such as the heart, lung, liver …
Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer
R Mhaidly, F Mechta‐Grigoriou - Immunological reviews, 2021 - Wiley Online Library
The tumor microenvironment (TME) has been identified as one of the driving factors of tumor
progression and invasion. Within this microenvironment, cancer‐associated fibroblasts …
progression and invasion. Within this microenvironment, cancer‐associated fibroblasts …
Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells
S Li, M Liu, MH Do, C Chou, EG Stamatiades… - Nature, 2020 - nature.com
Cancer arises from malignant cells that exist in dynamic multilevel interactions with the host
tissue. Cancer therapies aiming to directly kill cancer cells, including oncogene-targeted …
tissue. Cancer therapies aiming to directly kill cancer cells, including oncogene-targeted …
Exploiting innate immunity for cancer immunotherapy
M Yi, T Li, M Niu, Q Mei, B Zhao, Q Chu, Z Dai, K Wu - Molecular cancer, 2023 - Springer
Immunotherapies have revolutionized the treatment paradigms of various types of cancers.
However, most of these immunomodulatory strategies focus on harnessing adaptive …
However, most of these immunomodulatory strategies focus on harnessing adaptive …
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
Immune checkpoint inhibitors (ICIs) have revolutionized the clinical management of multiple
tumours. However, only a few patients respond to ICIs, which has generated considerable …
tumours. However, only a few patients respond to ICIs, which has generated considerable …
Progress and prospect of immunotherapy for triple-negative breast cancer
C Luo, P Wang, S He, J Zhu, Y Shi, J Wang - Frontiers in Oncology, 2022 - frontiersin.org
Breast cancer is the most commonly diagnosed cancer (estimated 2.3 million new cases in
2020) and the leading cause of cancer death (estimated 685,000 deaths in 2020) in women …
2020) and the leading cause of cancer death (estimated 685,000 deaths in 2020) in women …